Announce Date | 06/11/2025 |
EPS Normalized Actual | $-0.785 (Miss by $-0.045) |
EPS GAAP Actual | $-0.785 (Miss by $-0.045) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2025 | -1.4694 | -0.15 | -3.42 | 0.49361 | 13 |
Dec 2024 | -0.75 | -0.29 | -3.31 | 1.83 | 18 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0 | 0 | 0B | -INF% | 0M |
FQ3 2024 (Sep 2024) | -0.98 | -0.98 | 0.235294B | 15.68% | 235.29M |
FQ2 2024 (Jun 2024) | -0.64 | -0.64 | 0.219597B | 24.24% | 219.6M |
FQ1 2024 (Mar 2024) | -0.57 | -0.57 | 0.160904B | -0.49% | 160.9M |
FQ4 2023 (Dec 2023) | -0.0015 | -0.0015 | 0.194182B | -0.73% | 194.18M |
FQ3 2023 (Sep 2023) | -0.53 | -0.53 | 0.198398B | 24.71% | 198.4M |
FQ2 2023 (Jun 2023) | -0.74 | -0.74 | 0.166377B | 11.64% | 166.38M |
FQ1 2023 (Mar 2023) | -0.96 | -0.96 | 0.161696B | 100% | 161.7M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 0.03 | -- | 0.02517536 | 0.0344219 | 1 |
FQ3 2029 (Sep 2029) | 0 | -- | 0 | 0 | 3 |
FQ2 2029 (Jun 2029) | 0 | -- | 0 | 0 | 3 |
FQ1 2029 (Mar 2029) | 0 | -- | 0 | 0 | 3 |
FQ4 2028 (Oct 2028) | 0.08 | -- | 0.05901522 | 0.09570407 | 7 |
FQ3 2028 (Jul 2028) | 0.04 | -- | 0.02950761 | 0.04785203 | 7 |
FQ2 2028 (Jun 2028) | 0.34 | -- | 0.24228 | 0.4088 | 7 |
FQ1 2028 (Mar 2028) | -0.15 | -- | -0.18035 | -0.10689 | 7 |
FQ4 2027 (Oct 2027) | -0.07 | -- | -0.08374106 | -0.05163832 | 6 |
FQ3 2027 (Sep 2027) | 0.41 | -- | 0.29216 | 0.49296 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 0.44B | -- | 0.38B | 0.48B | 4 |
FQ3 2029 (Sep 2029) | 0.62B | -- | 0.54B | 0.72B | 10 |
FQ2 2029 (Jun 2029) | 0.6B | -- | 0.52B | 0.69B | 7 |
FQ1 2029 (Mar 2029) | 0.44B | -- | 0.38B | 0.51B | 5 |
FQ4 2028 (Oct 2028) | 0.65B | -- | 0.51B | 0.74B | 7 |
FQ3 2028 (Jul 2028) | 0.61B | -- | 0.49B | 0.7B | 7 |
FQ2 2028 (Jun 2028) | 0.64B | -- | 0.5B | 0.74B | 6 |
FQ1 2028 (Mar 2028) | 0.46B | -- | 0.35B | 0.53B | 6 |
FQ4 2027 (Oct 2027) | 0.55B | -- | 0.44B | 0.63B | 8 |
FQ3 2027 (Sep 2027) | 0.59B | -- | 0.46B | 0.69B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
7
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | -0.98 | -0.98 | 100% | |
FQ2 2024 (Jun 2024) | -0.64 | -0.64 | 100% | |
FQ1 2024 (Mar 2024) | -0.57 | -0.57 | 100% | |
FQ4 2023 (Dec 2023) | -0.0015 | -0.0015 | 100% | |
FQ3 2023 (Sep 2023) | -0.53 | -0.53 | 100% | |
FQ2 2023 (Jun 2023) | -0.74 | -0.74 | 100% | |
FQ1 2023 (Mar 2023) | -0.96 | -0.96 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
FQ3 2024 (Sep 2024) | $0B | $0.24B | $235.29M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.22B | $219.6M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.16B | $160.9M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.19B | $194.18M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.2B | $198.4M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.17B | $166.38M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.16B | $161.7M | 100% |